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Objective/purpose
Genetic association studies have identified several poly-
morphisms in genes of the innate immunity cascade
that appear to influence susceptibility to asthma and
other inflammatory diseases. However, most candidate
genes have not been functionally characterized for their
impact on human immune responsiveness. An excellent
candidate for functional investigation is NFKBIA which
encodes IBa–the major negative regulator of NFB.
Single nucleotide polymorphisms (SNPs) in the promo-
ter region of NFKBIA have been implicated in various
infectious and inflammatory diseases. Specifically, the
linked promoter SNPs rs2233406, rs3138053 and
rs2233409 have been implicated in sarcoidosis, tra-
choma, acute respiratory distress syndrome, invasive
pneumococcal disease, Graves’ disease and respiratory
syncytial virus. We investigated the mechanistic and
functional impact of the promoter variants of NFKBIA
on human immune responsiveness.
Methods
Using a coding SNP that was in high linkage with
NFKBIA SNPs rs3138053/rs2233406/rs2233409, we
designed and validated an allele-specific PCR assay that
could detect subtle differences in allele ratios between
the major (ACC) and minor (GTT) promoter variants of
SNPs rs3138053/rs2233406/rs2233409. Peripheral blood
mononuclear cells of homozygous (ACC/ACC) and het-
erozygous (ACC/GTT) individuals were stimulated with
LPS and live cultures of Streptococcus pneumoniae
(serotype 14) for 3 and 4 hours. PBMCs of NFKBIA
homozygotes and heterozygotes were stimulated with
various Toll-like-receptor (TLR) ligands of the innate
immune cascade to assay for differences in the innate
immune response.
Findings
NFKBIA heterozygotes (ACC/GTT) displayed 1.21 (1.14-
1.27 95% CI) - 1.26 (1.18-1.34 95% CI) fold higher
expression of the major allele transcript (ACC) relative
to the minor allele transcript (GTT). At 3 hours post
stimulation, NFKBIA homozygotes (ACC/ACC) pro-
duced higher level of NFKBIA mRNA than heterozy-
gotes (ACC/GTT) following stimulation with LPS (1.4
fold, p = 0.0095) or S. pneumoniae (1.51 fold, p =
0.024). Higher TNF-a secretion was seen from the per-
ipheral blood mononuclear cells (PBMCs) of heterozy-
gotes (ACC/GTT) as compared to homozygotes (ACC/
ACC) when stimulated with Pam3CSK4 (2.29-fold
increase; p < 0.01) and 3M-002 (3.30-fold increase; p <
0.001).
Deliverables
We have shown that the observed association of
NFKBIA variants with infectious and inflammatory con-
ditions has functional consequences. Individuals hetero-
zygous for SNPs rs3138053 /rs2233406/rs1050851
display allelic imbalance, reduced levels of NFKBIA
expression, as well as a hyper inflammatory innate
immune response.
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Relevance
Functional genomic studies such as this will help realize
AllerGen’s goal of ‘discovery of the causes of, and ways
to prevent, control or eliminate allergic and related
immune diseases’ by:
• Generating convincing evidence that the genetic
variant is functionally relevant and likely to contri-
bute to the development of the clinical phenotype.
• Providing insight into the mechanism underlying
the genetic association and, therefore, greatly enhan-
cing our knowledge of the disease pathogenesis.
• Identifying molecular pathways that can be tar-
geted to prevent or treat allergic disease.
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